Skin Substitutes Market
Skin substitutes market size, share, and industry analysis, By Product Type (Biological Skin Substitutes, Synthetic Skin Substitutes), By Application (Burns, Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Others), By end user (hospitals, wound care centres, speciality Clinics), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa): Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Market Overview:
“The skin substitutes The market is expected to develop at a 7.8% CAGR from 2024 to 2031. The market value is predicted to rise from XX USD in 2024 to YY USD in 2031, with North America emerging as the leading area.”
The expanding occurrence of chronic wounds, the growing geriatric population, and advances in tissue engineering technology are among the key metrics. The rising incidence of diabetes and its complications, rising burn injuries, and increased usage of advanced wound care products are all driving market expansion.
Skin Substitutes Market Dynamics:
Market Trend: Shift towards bioengineered skin substitutes
The skin substitutes market is seeing a considerable increase in the development and acceptance of bioengineered skin substitutes. These sophisticated products are intended to more closely resemble the structure and function of real skin, resulting in better wound healing and tissue regeneration.
Bioengineered skin substitutes frequently integrate growth factors, stem cells, and other bioactive substances to improve therapeutic efficacy. The increasing demand for more effective wound healing options, combined with the limits of standard skin grafts, is driving this trend. For example, living cell-based therapies such as Apligraf and dermagraft have grown in popularity due to their ability to promote quicker healing in chronic wounds.
Market Driver: Rising prevalence of chronic wounds and diabetic foot ulcers
The rising prevalence of chronic wounds, particularly diabetic foot ulcers, is a significant driver of the skin replacement market. According to the International Diabetes Federation, around 463 million people worldwide had diabetes in 2019, with this figure expected to climb to 700 million by 2045. Diabetes foot ulcers impact around 15% of diabetes patients over their lifetime, resulting in a high demand for sophisticated wound care solutions such as skin substitutes. In the United States alone, the yearly cost of treating diabetic foot ulcers is estimated to be $9–13 billion, underscoring the economic burden and the need for efficient treatment solutions. This growing patient population, combined with rising healthcare costs for wound treatment, is fuelling demand for skin replacements and propelling market expansion.
Market Restraint: High costs associated with skin substitute products and treatments
The high costs of skin substitute products and treatments are a significant barrier to market expansion, especially in poor countries. Advanced skin replacements can be expensive, with some products costing thousands of dollars per application. For example, a single application of certain bioengineered skin substitutes can cost between $1,500 and $2,000. Certain high costs may limit access to certain treatments, particularly in healthcare systems with limited resources or inadequate insurance coverage.
Furthermore, the requirement for several applications in some situations raises overall therapy costs, thereby discouraging healthcare professionals and patients from choosing these advanced medicines.
Segment Overview:
The biological skin substitutes segment is expected to dominate the market throughout the forecast period.
Biological skin substitutes have emerged as the industry leader due to their superior healing properties and similarity to genuine skin. These products, produced from human or animal tissues, improve wound healing by stimulating cell migration, angiogenesis, and tissue regeneration. This segment's dominance is due to an increased desire for natural and biocompatible materials in wound care.
Recent advances in biological skin substitutes have strengthened their market position. For example, the introduction of acellular dermal matrices (ADMs) has transformed difficult wound treatment. These products, such as AlloDerm and DermACELL, serve as scaffolds for tissue regeneration while reducing the risk of immunological rejection.
According to our research analysis, the global acellular dermal matrix market, a crucial sub-segment of biological skin substitutes, is predicted to reach $3.5 billion by 2025, with a 9.2% compound annual growth rate.
The biological skin replacement market has also benefited from increased research into new biomaterials and tissue engineering techniques. For example, incorporating growth hormones and stem cells into biological skin substitutes has shown promise in expediting wound healing. A study published in the Journal of Tissue Engineering and Regenerative Medicine found that stem cell-seeded biological skin substitutes closed wounds 40% faster than standard therapies for diabetic foot ulcers.
Regional Outlook:
North America is expected to dominate the skin substitutes market during the forecast period.
Several reasons contribute to North America's dominant position in the skin replacement market, including modern healthcare infrastructure, a high frequency of chronic wounds, and favorable reimbursement regulations. The region has seen a considerable growth in the aging population and the prevalence of diabetes, both of which contribute to the growing demand for advanced wound care solutions. According to the American Diabetes Association, roughly 34.2 million Americans (10.5% of the population) had diabetes in 2018, with a large percentage at risk of developing diabetic foot ulcers.
Recent advancements in the North American market include the launch of new skin substitute products as well as increased indications for existing treatments. For example, in 2021, Organogenesis Holdings Inc. got FDA approval for ReNu, a cryopreserved amniotic solution, for the treatment of knee osteoarthritis, broadening its use beyond wound care.
Key figures demonstrate the market potential in North America. The U.S. wound care market, which includes skin replacements, was valued at $9.4 billion in 2020 and is expected to reach $15.8 billion by 2027, rising at a 7.6% CAGR.
Furthermore, the use of advanced wound care treatments, such as skin replacements, has been continuously expanding, with an estimated annual growth rate of 8-10% in recent years.
In terms of country-specific advances, Canada has seen increased use of skin replacements, aided by attempts to expand access to advanced wound care therapies. The Canadian Agency for Drugs and Technologies in Health (CADTH) has been actively investigating the clinical and cost-effectiveness of numerous skin substitutes, assisting in informed decision-making and market expansion in the country.
Competitive Intelligence:
The skin replacements industry is characterized by fierce rivalry among significant competitors, with an emphasis on product innovation and strategic alliances. Organogenesis Holdings Inc., Smith & Nephew plc, and MiMedx Group, Inc. are among the industry leaders, owing to their wide product portfolios and robust distribution networks. These firms have made significant investments in R&D to create innovative skin substitute products with superior healing qualities and broader applications.
Recent market trends show an increasing emphasis on the development of off-the-shelf skin substitutes with longer shelf life and easier storage. Integra LifeSciences' PriMatrix Dermal Repair Scaffold, for example, has grown in popularity because of its room-temperature storage capability and quick usability.
Mergers and acquisitions have also played an important role in defining the competitive landscape. Smith & Nephew purchased Osiris Therapeutics, Inc. for $660 million in 2019, bolstering its presence in the regenerative medicine and skin substitute markets. This strategic move broadened Smith & Nephew's product line to include Grafix, a cryopreserved placental membrane for acute and chronic wounds.
As per our analysis that the market's top companies have maintained significant profit margins, which typically range between 15% and 25%. However, increased competition from developing firms, as well as the arrival of biotechnology companies into the skin replacements industry, are projected to have an impact on pricing tactics and market share in the next few years.
The future forecast for the skin replacements market is good, with chances for growth in emerging nations and the possibility of technical breakthroughs driving market expansion. Companies that can provide cost-effective solutions without sacrificing product efficacy are expected to acquire a competitive advantage in this expanding sector.
Analyst Opinion:
The skin substitutes market is expected to rise significantly, owing to the rising prevalence of chronic wounds, advances in tissue engineering, and increased acceptance of regenerative medicine technologies. A unique market trend is the development of personalised skin substitutes utilising 3D bioprinting technology, which has the potential to revolutionise wound treatment by offering custom-made grafts suited to specific patient needs.
Major Players:
-
Organogenesis Holdings Inc.
-
Smith & Nephew plc
-
MiMedx Group, Inc.
-
Integra LifeSciences Holdings Corporation
-
Allergan (now part of AbbVie Inc.)
-
Tissue Regenix Group plc
-
Mallinckrodt plc
-
Axogen, Inc.
-
Straumann Holding AG
-
Lattice Biologics Ltd.
Key Developments:
-
July 2023: Organogenesis Holdings Inc. introduced a new line of advanced wound care products with antibacterial capabilities to improve infection control.
-
Smith & Nephew plc got FDA approval for its innovative bioengineered skin substitute for the treatment of venous leg ulcers in April 2023.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope and Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking—Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies List by Country) (Premium)
5. COMPANY PROFILES
5.1. Organogenesis Holdings Inc.
5.2. Smith & Nephew plc
5.3. MiMedx Group, Inc.
5.4. Integra LifeSciences Holdings Corporation
5.5. Allergan (now part of AbbVie Inc.)
5.6. Tissue Regenix Group plc
5.7. Mallinckrodt plc
5.8. Axogen, Inc.
5.9. Straumann Holding AG
5.10. Lattice Biologics Ltd. (LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Shift towards bioengineered skin substitutes
6.1.2. Development of personalised skin substitutes using 3D bioprinting technology
6.1.3. Increasing adoption of off-the-shelf skin substitutes
6.2. Market Drivers
6.2.1. Rising prevalence of chronic wounds and diabetic foot ulcers
6.2.2. Advancements in tissue engineering technologies
6.2.3. Growing geriatric population and increasing incidence of burn injuries
6.3. Market Restraints
6.3.1. High costs associated with skin substitute products and treatments
6.3.2. Regulatory challenges and lengthy approval processes
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY PRODUCT TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Biological Skin Substitutes
7.2. Synthetic skin Substitutes
8. BY APPLICATION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH)--2020-2031)
8.1. Burns
8.2. Diabetic Foot Ulcers
8.3. Venous Leg Ulcers
8.4. Pressure Ulcers
8.5. Others
9. BY END USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. Hospitals
9.2. Wound Care Centres
9.3. Speciality Clinics
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (2020-2031)
Skin substitutes market segmentation:
By Product Type:
-
Biological skin substitutes
-
Synthetic skin substitutes
By Application:
-
Burns
-
Diabetic Foot Ulcers
-
Venous Leg Ulcers
-
Pressure ulcers
-
Others
By End User:
-
Hospitals
-
Wound Care Centres
-
Speciality Clinics
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511